Corporate Wellness · B2B · HR & Benefits

Metabolic health programs
for high-performance teams

A group metabolic evaluation program for executive teams and employee cohorts. Clinical precision, measurable outcomes, and data that supports the ROI conversation with benefits leadership.

The Gap in Most Corporate Wellness Programs

Most corporate wellness programs measure participation, not outcomes. Employees complete a biometric screening — height, weight, blood pressure, basic cholesterol — and receive a report that says "see your doctor if anything is out of range." Nothing is out of range for most employees. Nothing changes.

The Valens MD corporate program is built on a different premise: measure the markers that actually predict the health costs and performance losses that concern CFOs and benefits directors, then provide a pathway to address them.

Why Metabolic Health Is a Business Issue

📊

Metabolic Disease Is Your Largest Health Cost

Diabetes and prediabetes account for over 25% of total employer health spending. The majority of that cost is in employees who had detectable metabolic dysfunction years before their diagnosis — and were never identified.

🧠

Cognitive Performance Is Metabolically Driven

Insulin resistance impairs prefrontal cortex function. In a knowledge-work organization, that impairment — typically subclinical and undiagnosed — is a direct drag on the output that matters most.

📋

Standard Screenings Miss the Problem

Fasting glucose and HbA1c catch metabolic dysfunction at diagnosis — 10 to 15 years after it began. The Valens MD panel identifies it at the intervention stage, when reversal is straightforward.

🎯

Individual Results, Group Data

Each participant receives a personal evaluation and Plan of Care. HR and benefits leadership receive a de-identified group metabolic health report — aggregate tier distribution, key findings, and recommended follow-up pathways.

How the Program Works

1

Intake & Scheduling

We coordinate directly with HR. Participants receive pre-visit instructions and intake forms. Morning half-day blocks accommodate 5–8 participants per session.

2

Group Evaluation Day

Each participant completes the full Valens MD evaluation: metabolic panel, body composition, functional testing, and physician consultation. On-site or at our Miami clinic.

3

Individual Reports

Each participant receives their tier classification, full biomarker results, and a personalized Plan of Care within 48 hours of their evaluation.

4

Group Health Report

HR and leadership receive a de-identified summary: aggregate tier distribution, prevalence findings, and recommended program next steps.

Program Pricing

Program Group Size Per-Participant Includes
Executive Team 5–10 participants $695/person Full evaluation, individual Plan of Care, group report
Department Cohort 11–25 participants $595/person Full evaluation, Plan of Care, group report, 90-day follow-up option
Enterprise Program 26+ participants Custom pricing Full program design, on-site evaluation option, quarterly reassessment

The ROI Case

The average annual employer cost for an employee with Type 2 diabetes is approximately $16,000 — roughly 2.3× the cost of an employee without the condition. A Valens MD evaluation that identifies and initiates reversal of Tier 3 insulin resistance costs under $800 per employee. The math is straightforward — and the group health report gives benefits leadership the data to make it.

Frequently Asked Questions

For groups of 15 or more, on-site evaluation is available in the Miami area. We bring the equipment and clinical team. For smaller groups, evaluations are conducted at our Miami clinic in scheduled half-day blocks.

Individual results are strictly confidential and delivered directly to each participant — not to HR or leadership. The group report contains only de-identified aggregate data. Participation is voluntary and HIPAA-compliant.

Yes. Corporate wellness programs of this type are typically funded through employee benefits, wellness, or preventive health budgets. We provide invoicing in whatever format your finance team requires.

We offer structured 90-day follow-up evaluations for corporate cohorts, with repeat biomarkers and documented protocol progress. For enterprise programs, quarterly cohort reassessment with updated group health reports is available.

Bring Valens MD to your team.

Reach out to discuss group scheduling, program structure, and pricing for your organization.

Request Program Overview →